# FDA Inspection 1226692 - Pillar5 Pharma Inc. - December 15, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/pillar5-pharma-inc/d18f4f76-6e8e-4741-826d-9fbbd52772fb
Source feed: FDA_Inspections

> FDA Inspection 1226692 for Pillar5 Pharma Inc. on December 15, 2023. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1226692
- Company Name: Pillar5 Pharma Inc.
- Inspection Date: 2023-12-15
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1261773 - 2025-02-07](https://www.globalkeysolutions.net/records/fda_inspections/pillar5-pharma-inc/4d585495-e870-4a98-bc55-0302c9f96034)
- [FDA Inspection 1261773 - 2025-02-07](https://www.globalkeysolutions.net/records/fda_inspections/pillar5-pharma-inc/9bde498e-2566-4025-8c5b-53bacfb5ac30)
- [FDA Inspection 1261773 - 2025-02-07](https://www.globalkeysolutions.net/records/fda_inspections/pillar5-pharma-inc/e135bdf9-ed1a-4ef9-8d9c-e584d1d5e5ab)
- [FDA Inspection 1261773 - 2025-02-07](https://www.globalkeysolutions.net/records/fda_inspections/pillar5-pharma-inc/75315d01-02ba-4fbf-b73a-07cff71e8be9)
- [FDA Inspection 1226692 - 2023-12-15](https://www.globalkeysolutions.net/records/fda_inspections/pillar5-pharma-inc/1c30bf78-de6b-4e30-9cd1-131e956f9474)

Company: https://www.globalkeysolutions.net/companies/pillar5-pharma-inc/8b94b834-f2da-4821-9ddc-6795a5e6d6f0

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c